RareSearch logo

Seattle Children's Hospital Research Institute - Center for Global Infectious Disease Research

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Taylor Botsford profile

Taylor Botsford

🇮🇹 Italy

6.5

    Reviewed:

  • - Regulatory Submission
  • - 8 weeks May - July 2024
  • - Pharmaceutical Company

Regulatory submission was incomplete, required additional work.

The initial regulatory submission provided was incomplete, requiring additional work to meet the necessary standards. This resulted in unexpected costs and delays. The team corrected the issues, but it should have been right the first time.

Nellie Murazik profile

Nellie Murazik

🇮🇹 Italy

6

    Reviewed:

  • - Health Technology Assessment
  • - 8 weeks July - September 2024
  • - Pharmaceutical Company

Health technology assessment was superficial, lacked thorough analysis.

The health technology assessment (HTA) was superficial and did not provide the level of thorough analysis we needed. Some important factors were overlooked, and we had to request additional work to cover these gaps. The overall experience was disappointing.

Ruben Rosenbaum profile

Ruben Rosenbaum

🇩🇪 Germany

8.9

    Reviewed:

  • - Medical Writing
  • - 5 weeks October - November 2023
  • - Biotech Company

Top-quality medical writing, clear and precise documents.

The medical writing services provided were of top quality. The documents were clear, precise, and tailored to meet the specific requirements of our regulatory submissions. The team's expertise was evident throughout the process.

Della Bailey profile

Della Bailey

🇦🇺 Australia

9.2

    Reviewed:

  • - Data Analysis
  • - 4 weeks January 2023
  • - Pharmaceutical Company

Thorough data analysis, timely delivery, excellent communication throughout.

The team provided exceptional data analysis services, and the project was completed well within the timeline. Communication was clear and consistent, which made the whole process smooth. Highly recommended for anyone needing reliable clinical data management.

Mr. Alonzo Thiel PhD profile

Mr. Alonzo Thiel PhD

🇨🇦 Canada

6.3

    Reviewed:

  • - Stability Studies
  • - 16 months July 2023 - November 2024
  • - Pharmaceutical Company

Stability studies lacked detail, required additional validation.

The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.